Search bioRxiv⌕ Search

Biology subjects

Nieto, P. A.

Publications and source records attributed to Nieto, P. A..

2 recordsLinked to original sources

Integrating stool chemistry measurements with metagenomics in adults reveals distinct gut health profiles

Stool chemistry metrics, including calprotectin, lactoferrin, and secretory IgA, are used to assess gut inflammation in clinical or research settings. However, these measures in isolation provide a limited view of gut physiology and lack microbial context. Shotgun metagenomics offers a comprehensive assessment of the gut microbiome's taxonomic composition and functional potential, yet its integration with stool chemistry metrics remains underexplored. We analyzed 877 adult stool samples with paired shotgun metagenomic sequencing and chemistry measurements to integrate the microbiome with 12 stool chemistry metrics. Calprotectin, lactoferrin, and secretory IgA were associated with shifts in microbiome composition (beta diversity), while deviations from typical levels of short-chain fatty acids (SCFAs), including butyrate, were associated with both changes in alpha diversity and microbiome composition. Network analysis revealed two distinct microbial neighborhoods: one associated with higher butyrate and lower calprotectin and lactoferrin and another associated with lower butyrate and higher calprotectin and lactoferrin. Machine learning models trained on taxonomic and functional data showed modest discrimination of stool chemistry states, performing best for SCFA deficiency and less well for host-derived inflammatory metrics. Together, these findings systematically characterize microbiome-stool chemistry relationships across a large paired dataset, providing a framework for interpreting stool chemistry metrics in the context of shotgun metagenomic profiles.

microbiology↗

A new sequencing-based women’s health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis

The composition of the vaginal microbiome, including both the presence of pathogens involved in sexually transmitted infections (STI) as well as commensal microbiota, has been shown to have important associations for a womans reproductive and general health. Currently, healthcare providers cannot offer comprehensive vaginal microbiome screening, but are limited to the detection of individual pathogens, such as high-risk human papillomavirus (hrHPV), the predominant cause of cervical cancer. There is no single test on the market that combines HPV, STI, and microbiome screening. Here, we describe a novel inclusive womens health assay that combines self-sampling with sequencing-based HPV detection and genotyping, vaginal microbiome analysis, and STI-associated pathogen detection. The assay includes genotyping and detection of 14 hrHPV types, 5 low-risk HPV types (lrHPV), as well as the relative abundance of 32 bacterial taxa of clinical importance, including Lactobacillus, Sneathia, Gardnerella, and 4 pathogens involved in STI, with high sensitivity, specificity, and reproducibility. For each of these taxa, healthy ranges were determined in a group of 50 self-reported healthy women. The hrHPV portion of the test was evaluated against the Digene High-Risk HPV HC2 DNA test with vaginal samples obtained from 185 women. Results were concordant for 181/185 of the samples (overall agreement of 97.83%, Cohens kappa = 0.93), with sensitivity and specificity values of 94.74% and 98.64%, respectively. Two discrepancies were caused by the Digene assays known cross-reactivity with low-risk HPV types, while two additional samples were found to contain hrHPV not detected by Digene. This novel assay could be used to complement conventional cervical cancer screening, because its self-sampling format can expand access among women who would otherwise not participate, and because of its additional information about the composition of the vaginal microbiome and the presence of pathogens.

microbiology↗